Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases

H Li, J Zuo, W Tang - Frontiers in pharmacology, 2018 - frontiersin.org
Phosphodiesterase-4 (PDE4), mainly present in immune cells, epithelial cells, and brain
cells, manifests as an intracellular non-receptor enzyme that modulates inflammation and …

Oxidative stress in ozone-induced chronic lung inflammation and emphysema: a facet of chronic obstructive pulmonary disease

CH Wiegman, F Li, B Ryffel, D Togbe… - Frontiers in …, 2020 - frontiersin.org
Oxidative stress plays an important role in the pathogenesis of chronic obstructive
pulmonary disease (COPD) caused by cigarette smoke and characterized by chronic …

Machine-learning algorithm-based prediction of diagnostic gene biomarkers related to immune infiltration in patients with chronic obstructive pulmonary disease

Y Zhang, R Xia, M Lv, Z Li, L Jin, X Chen… - Frontiers in …, 2022 - frontiersin.org
Objective This study aims to identify clinically relevant diagnostic biomarkers in chronic
obstructive pulmonary disease (COPD) while exploring how immune cell infiltration …

The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable Haemophilus influenzae

YC Su, F Jalalvand, J Thegerström… - Frontiers in …, 2018 - frontiersin.org
Chronic obstructive pulmonary disease (COPD) is a debilitating respiratory disease and one
of the leading causes of morbidity and mortality worldwide. It is characterized by persistent …

[PDF][PDF] COPD as a Disease of Immunosenescence

WK Cho, CG Lee, LK Kim - Yonsei medical journal, 2019 - synapse.koreamed.org
Although chronic obstructive pulmonary disease (COPD) is regarded as a chronic
inflammatory lung disease, the disease mechanism is still not known. Intriguingly, aging …

The persistent inflammation in COPD: is autoimmunity the core mechanism?

LL Dong, ZY Liu, KJ Chen, ZY Li… - European …, 2024 - Eur Respiratory Soc
COPD poses a significant global public health challenge, primarily characterised by
irreversible airflow restriction and persistent respiratory symptoms. The hallmark pathology …

Immune modulation via T regulatory cell enhancement: Disease‐modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory …

F Roth‐Walter, IM Adcock, C Benito‐Villalvilla… - Allergy, 2021 - Wiley Online Library
Therapeutic advances using targeted biologicals and small‐molecule drugs have achieved
significant success in the treatment of chronic allergic, autoimmune, and inflammatory …

The lymphatic vasculature in lung function and respiratory disease

A Trivedi, HO Reed - Frontiers in Medicine, 2023 - frontiersin.org
The lymphatic vasculature maintains tissue homeostasis via fluid drainage in the form of
lymph and immune surveillance due to migration of leukocytes through the lymphatics to the …

How do innate immune cells contribute to airway remodeling in COPD progression?

T Bu, LF Wang, YQ Yin - International Journal of Chronic …, 2020 - Taylor & Francis
Recently, the therapeutic potential of immune-modulation during the progression of chronic
obstructive pulmonary disease (COPD) has been attracting increasing interest. However …

Single-cell transcriptomics highlights immunological dysregulations of monocytes in the pathobiology of COPD

Q Huang, Y Wang, L Zhang, W Qian, S Shen… - Respiratory …, 2022 - Springer
Background Chronic obstructive pulmonary disease (COPD) is a common respiratory
disease, whose pathogenetic complexity was strongly associated with aging/smoking and …